Last $30.71 USD
Change Today -0.34 / -1.10%
Volume 2.2M
PTLA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

R. Lee Douglas

AgeTotal Calculated CompensationThis person is connected to 30 board members in 3 different organizations across 6 different industries.

See Board Relationships
63--

Background*

Mr. R. Lee Douglas is an Advisor of Portola Pharmaceuticals Inc. and Five Prime Therapeutics Inc. Mr. Douglas Co-founded COR Therapeutics Inc. While at COR, he served in a number of key management positions, including as its original Chief Executive Officer, later as Chief Financial Officer. He is a Director of Calistoga Pharmaceuticals, Inc. He has been a Director of FivePrime Therapeutics Inc since January 2002. Mr. Douglas served as a Director at Affymax Inc. from ...

Read Full Background

Corporate Headquarters*

270 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-246-7300
Fax: 650-246-7376

Board Members Memberships*

Director
Former Director
2002-Present
Director and Member of Audit Committee
2004-2011
Former Director and Member of Compensation Committee
2008-Present
Director

Education*

Unknown/Other Education
Harvard University
Master's Degree
Harvard University
MBA
Harvard Business School
BA
University of North Carolina at Charlotte

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PTLA:US $30.71 USD -0.34

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PORTOLA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.